Research use onlyNot for human or veterinary use
Encore Bio Labs CartExplore catalog
ENCORE BIO LABSRESEARCH COLLECTION
Thymosin Alpha-1 — complete Encore Bio Labs reference vialMATERIAL / 23

Reference artwork · Legacy packaging may be shown.
Listed identity and formats take precedence over the image.

Research material

Thymosin Alpha-1

How do immune cells respond to a signal? Thymosin Alpha-1 brings that question to the foreground. Studies in cultured mouse dendritic cells examine maturation and signaling, making this 28-amino-acid peptide interesting for understanding how immune responses take shape at the cellular level.

CAS
62304-98-7

Formats & reference pricing

USD
Listed formatReference price
10 mg$139 USD

Reference prices describe the listed formats. They do not confirm availability or constitute an offer for sale.

Review product documentation

For laboratory research only. Not for human or veterinary use.

About the reference identity

A specific member of the thymosin names

Thymosin alpha-1 is indexed as thymalfasin, with a reference sequence of 28 amino-acid residues and an acetyl group at its beginning. The alpha-1 designation matters: thymosin beta4 is a different peptide, not another spelling of the same substance. Sequence and terminal groups help distinguish those identities.

Reference synonym
Thymalfasin
Reference structure
28 residues with an N-terminal acetyl group

Reference identity only; not a test result for current inventory.

01 / Material overview

The specifications.

Catalog identity
Thymosin Alpha-1
CAS
62304-98-7
Listed formats
10 mg
Reference price range
$139 USD
Intended setting
Qualified laboratory or institutional research
Inventory specifications
Independent inventory review pending

02 / Regulatory context

Regulatory & safety notes.

FDA’s public compounding materials can provide regulatory safety context. They do not verify a current Encore Bio Labs lot.

FDA PUBLIC RECORD · REVIEWED OCT 2026Thymosin Alpha-1

FDA compounding record · Thymosin Alpha-1

FDA lists thymosin-alpha-1 among withdrawn bulk-substance nominations and describes potential significant immunogenicity and characterization concerns, stating that the available safety-related information is inadequate to sufficiently understand the extent of potential safety issues.

The FDA record does not establish approval, efficacy, or current-lot quality for this catalog material.

FDA record type
Human drug compounding safety context
Human-use guidance
Not provided

External public record

FDA · Bulk drug substances and potential safety risks

03 / Supporting records

Documentation.

Read the Encore summary, the scope of related reports and the status of privacy-redacted supplier copies.

No authenticated certificate establishing current-inventory identity or specifications is published for Thymosin Alpha-1 in this catalog.

Encore documentary summary · not a laboratory-issued COA

Report availability
Not located in the reviewed set
Formats & scope
No related report was located in the reviewed set. This does not establish that no document exists elsewhere.
Report authenticity
No report to authenticate
Inventory evidence review
Report-to-inventory correspondence has not been independently established. No purity, quantity or activity result is attributed to current inventory.
Outstanding review
Obtain material- and format-specific supporting records; verify the issuer and the relationship to received inventory.
Product-specific SDS
Not located in the reviewed PDF set; applicability and verification pending.

Document inventory reviewed October 6, 2026. Related reports were commissioned by third parties, not Encore. Original customer details and internal records are not included here.

Privacy-redacted supplier report

Report not on file

Where prepared, these are copies redacted by Encore for privacy, not laboratory-issued public versions or Encore-commissioned tests. Analytical content is not replaced with Encore results.

Copy preparation
0 source files in redacted review copies. Duplicate file formats are not additional tests.
Supplier sharing permission
Owner-confirmed for supplied reports; this does not imply a report exists for every product. Report authentication is a separate check.
Privacy review
No source to review. Retained references and copies elsewhere can still identify the original customer; redaction does not guarantee anonymity.
Downloads
No website copy released. No download is available for this product.
Laboratory-issued public copy
Not available. Encore-prepared redactions are not an issuer reissue.

First locate the source report for the material and format; then review privacy, scope and verification.

A public copy does not by itself verify current inventory. No laboratory replacement or delivery date is promised.

Explore summary & report status

04 / A closer look

Common questions.

01Which Thymosin Alpha-1 formats and reference prices are listed?

10 mg: $139 USD. These are catalog quantities and reference prices, not usage instructions, stock confirmation or an offer for sale.

02Where can I find the Thymosin Alpha-1 reports?

Report not on file. The Documentation section on this page lists the reviewed source status and outstanding items for this material. No public PDF is available for this product; an unreleased or missing document is not a certificate of current inventory.

03Does the image establish the contents of a lot?

No. The image is owned Encore Bio Labs reference artwork and may show legacy packaging. Use the written identity and specifications, then verify the exact lot with supporting records.

04How should research suitability be assessed?

Qualified personnel should evaluate material identity, lot-specific records, institutional requirements, and study design. Report not on file. Independent inventory review remains pending, and no product-specific SDS was located in the reviewed set. This catalog provides no personal-use or preparation guidance.

Continue the collection

Next in the catalog.

View all materials